Publications of Tiago Fleming Outeiro
All genres
Journal Article (129)
61.
Journal Article
38 (2), pp. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 62.
Journal Article
12, pp. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 63.
Journal Article
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 64.
Journal Article
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 65.
Journal Article
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
66.
Journal Article
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 67.
Journal Article
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 68.
Journal Article
37 (1), pp. 39 - 51 (2022)
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders 69.
Journal Article
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 70.
Journal Article
87, pp. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 71.
Journal Article
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
72.
Journal Article
404, pp. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 73.
Journal Article
116 (51), pp. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 74.
Journal Article
28, pp. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 75.
Journal Article
47, pp. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 76.
Journal Article
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 77.
Journal Article
47 (3), pp. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 78.
Journal Article
85 (5), pp. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 79.
Journal Article
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 80.
Journal Article
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology